Abstract: The present invention relates to compounds comprising a heterocyclic group substituted with a fluoranthene group and a particular aromatic or heteroaromatic group. The compounds are suitable for use in electronic devices, in particular organic electroluminescent devices, comprising these compounds. In some embodiments, the compounds are used as matrix materials for phosphorescent or fluorescent emitters as well as a hole-blocking or an electron-transport layer.
Type:
Application
Filed:
October 6, 2016
Publication date:
February 21, 2019
Applicant:
Merck Patent GmbH
Inventors:
Amir Hossain PARHAM, Tobias GROSSMANN, Jonas Valentin KROEBER
Abstract: A sample preparation container, preferably for use in sterility testing, comprising a housing (1) having a housing wall (2) defining an inside space (3), a support on which a membrane filter is placed or is to be placed so as to get in contact with a sampling fluid to be introduced into the inside space (3), and at least one inlet opening (4) to the inside space (3) and at least one outlet opening from the inside space (3). A sampling port (5) is provided for allowing access from the outside to the inside space (3), wherein said sampling port (5) is closed by a septum (6) and the septum (6) is separated from the inside space (3) by a barrier wall (7) which is preferably piercable or breakable on application of an external force, preferably applied through a sampling instrument like a needle (8).
Abstract: The invention relates to a liquid-crystalline medium which comprises at least one compound of the formula I, in which R1, R1*, Z1, Z2 and L1-3 have the meanings defined herein, and to the use thereof for an active-matrix display, in particular based on the VA, PSA, PS-VA, PALC, FFS, PS-FFS, PS-IPS or IPS effect.
Type:
Grant
Filed:
October 28, 2016
Date of Patent:
February 19, 2019
Assignee:
MERCK PATENT GMBH
Inventors:
Harald Hirschmann, Monika Bauer, Martina Windhorst, Marcus Reuter, Constanze Brocke, Rocco Fortte, Matthias Bremer, Sabine Schoen
Abstract: The present invention relates to compacted glycine granules, where at least 75% of the granules have a particle size of above 0.7 mm, and to a process for the preparation and use of granules of this type.
Type:
Application
Filed:
January 24, 2017
Publication date:
February 14, 2019
Applicant:
Merck Patent GmbH
Inventors:
Harald BENK, Gudrun BIRK, Melina DECKER, Dieter LUBDA, Guenter MODDELMOG, Harald MUESSIG, Tanino SCARAMUZZA, Michael SCHLEEHAHN
Abstract: The present invention relates to compounds of the formula I and in particular medicaments comprising at least one compound of the formula I for use in the treatment and/or prophylaxis of physiological and/or pathophysiological conditions in the triggering of which cathepsin D is involved, in particular for use in the treatment and/or prophylaxis of arthrosis, traumatic cartilage injuries, arthritis, pain, allodynia or hyperalgesia.
Abstract: The present invention relates to compounds having polycyclic structural units and to electronic devices, in particular organic electroluminescent devices, containing said compounds.
Type:
Grant
Filed:
June 6, 2014
Date of Patent:
February 12, 2019
Assignee:
Merck Patent GmbH
Inventors:
Philipp Stoessel, Dominik Joosten, Nils Koenen
Abstract: Mixtures containing at least one dye compound having a diketopyrrolopyrrole structure and at least one further liquid-crystalline compound are suitable for use in devices for regulating the entry of light into a space.
Type:
Grant
Filed:
November 19, 2014
Date of Patent:
February 12, 2019
Assignee:
MERCK PATENT GMBH
Inventors:
Qiong Tong, Peer Kirsch, Michael Junge, Ursula Patwal, Andreas Beyer
Abstract: The invention relates to novel compounds containing one or more units derived from 2,6-disubstituted-[1,5]naphthyridine or 1,6-disubstituted-1H-[1,5]naphthyridine-2-one, to methods for their preparation and educts or intermediates used therein, to mixtures and formulations containing them, to the use of the compounds, mixtures and formulations as organic semiconductors in organic electronic (OE) devices, especially in organic photovoltaic (OPV) devices and organic photodetectors (OPD), and to OE, OPV and OPD devices comprising these compounds, mixtures or formulations.
Type:
Application
Filed:
December 30, 2016
Publication date:
February 7, 2019
Applicant:
Merck Patent GmbH
Inventors:
Lana NANSON, Nicolas BLOUIN, William MITCHELL, Joseph CAMERON, Peter SKABARA
Abstract: The present invention relates to novel pharmaceutical formulations which have controlled, delayed release of active ingredient, and to a process for the preparation of such formulations. The invention additionally relates to the use of these novel pharmaceutical administration forms as medicaments for the treatment of diseases which require delayed release of the active ingredient, such as hypertension, or asthmatic diseases.
Abstract: The present invention relates to a composition comprising a fluorescent material and a matrix material, a color conversion sheet and a light emitting diode device. The present invention further relates to the use of the composition in a color conversion sheet fabrication process, to the use of the color conversion sheet in optical devices or for agriculture purposes, and to the use of the fluorescent material and the matrix material in light emitting diode devices. Additionally, the invention relates to an optical device comprising the color conversion sheet and to a method for preparing the color conversion sheet and the optical device.
Abstract: The invention relates to a liquid-crystalline medium, which comprises one or more compounds of formula I in which denotes and the other the parameters have the meanings given in the text, to the use thereof in an electro-optical display, particularly in an active-matrix display based on the IPS or FFS effect, to displays of this type which contain a liquid-crystalline medium of this type, and to the use of the compounds of formula I for the improvement of the transmission and/or response times of a liquid-crystalline medium which comprises one or more additional mesogenic compounds.
Type:
Application
Filed:
July 27, 2018
Publication date:
January 31, 2019
Applicant:
Merck Patent GmbH
Inventors:
Eric XUE, Charles SONG, Hanny HAN, Mobius JAO, Enrico ZHANG, Andrew HUANG
Abstract: The application relates to a device for regulating the entry of light into a room, which comprises a switchable layer of specific design comprising a twisted nematic liquid-crystalline medium and a dichroic compound.
Type:
Application
Filed:
December 14, 2016
Publication date:
January 31, 2019
Applicant:
Merck Patent GmbH
Inventors:
Michael JUNGE, Andreas BEYER, Mila FISCHER
Abstract: The invention relates to a liquid-crystalline medium which comprises one or more compounds of the formula BO in which the parameters have the meanings indicated in Claim 1, to the use of the liquid-crystalline medium for electro-optical purposes, in particular in liquid-crystal light valves for lighting devices for motor vehicles, and to liquid-crystal light valves which comprise this medium and lighting devices for motor vehicles which contain such liquid-crystal light valves and to compounds of the formula BO.
Abstract: A composition is provided, including one or more quantum dots and at least one organic emitter. Further, a formulation including the composition, a use of the formulation and a device comprising the composition or formulation is provided.
Type:
Grant
Filed:
April 28, 2011
Date of Patent:
January 29, 2019
Assignee:
Merck Patent GmbH
Inventors:
Junyou Pan, Niels Schulte, Thomas Eberle, Volker Hilarius
Abstract: The invention relates to mesogenic media comprising one or more bimesogenic compounds, one or more nematogenic compound, one or more chiral compound and a compound of formula I, R11-A11-(Z12-A12)m-AG??I in which, the parameter A11, A12, Z12 and R11 have one of the meanings as given in claim 1, and to the use of these mesogenic media in liquid crystal devices and in particular in flexoelectric liquid crystal devices, as well as to liquid crystal devices comprising a liquid crystal medium according to the present invention.
Type:
Grant
Filed:
June 15, 2015
Date of Patent:
January 29, 2019
Assignee:
MERCK PATENT GMBH
Inventors:
Owain Ilyr Parri, Graziano Archetti, Simon Siemianowski, Izumi Saito, Rachel Tuffin
Abstract: The present application relates to an organic electroluminescent device (OLED) which has an emitting layer comprising a compound having a small difference between the energies of the S1 and T1 states, and in which certain conditions apply to the HOMO and LUMO energy levels of the emitting layer and the layers between the anode and the emitting layer.
Type:
Grant
Filed:
March 12, 2014
Date of Patent:
January 29, 2019
Assignee:
Merck Patent GmbH
Inventors:
Philipp Stoessel, Amir Hossain Parham, Christof Pflumm, Anja Jatsch, Joachim Kaiser
Abstract: The present application relates to a compound of a formula (I) which comprises a benzene group that is substituted with a group selected from carbazole derivatives and bridged amines and with an electron attracting group, wherein the two groups are located in the ortho-position in relation to one another. The present application further relates to the use of the compound of the formula (I) in an electronic device, and to a method of producing the compound of the formula (I).
Type:
Grant
Filed:
March 4, 2014
Date of Patent:
January 29, 2019
Assignee:
Merck Patent GmbH
Inventors:
Philipp Stoessel, Amir Hossain Parham, Christof Pflumm, Anja Jatsch
Abstract: The invention relates to a liquid-crystalline medium, preferably having a nematic phase and negative dielectric anisotropy, which comprises a) one or more compounds of formula I and b) one or more compounds selected from the group of compounds of the formulae II and III in which the parameters have the respective meanings indicated in claim 1, to the use thereof in an electro-optical display, particularly in an active-matrix display based on the VA, ECB, PALC, IPS or FFS effect, to displays of this type which contain a liquid-crystalline medium of this type, and to the use of the compounds of formula I for reduction of the dispersion of the birefringence of a liquid-crystalline medium which comprises one or more compounds of the formulae II and/or III.
Type:
Grant
Filed:
July 13, 2015
Date of Patent:
January 29, 2019
Assignee:
Merck Patent GmbH
Inventors:
Atsutaka Manabe, Sven Baran, Lars Lietzau, Brigitte Schuler